Why Rockwell Medical, Inc.’s (RMTI) Stock Is Down 11.22%
As of Thursday, September 18, Rockwell Medical, Inc.’s RMTI share price has dipped by 11.22%, which has investors questioning if this is right time to buy.Tudor Pop
Stock Evaluator: Rockwell Medical, Inc. (RMTI)
Rockwell Medical, Inc. RMTI
$6.94
-0.12
-1.70%
October 23, 2026 4:00:00 PM
EST
Volume: 13,259
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. The company’s hemodialysis concentrate products are used to sustain patient’s life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. In addition, it offers dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
Commentary & Analysis
Why Rockwell Medical, Inc.’s (RMTI) Stock Is Down 5.56%
As of Wednesday, September 10, Rockwell Medical, Inc.’s RMTI share price has dipped by 5.56%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Rockwell Medical, Inc.’s (RMTI) Stock Is Up 10.69%
As of Tuesday, September 09, Rockwell Medical, Inc.’s RMTI share price has surged by 10.69%, which has investors questioning if this is right time to sell.Tudor Pop
Why Rockwell Medical, Inc.’s (RMTI) Stock Is Down 6.16%
As of Monday, September 08, Rockwell Medical, Inc.’s RMTI share price has dipped by 6.16%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why Rockwell Medical, Inc.’s (RMTI) Stock Is Up 7.02%
As of Tuesday, September 02, Rockwell Medical, Inc.’s RMTI share price has surged by 7.02%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Financial Summary
| Share Statistics | RMTI | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $28.0 | $404.5 | 12% |
|
| Shares Out (Mil) | 4.0 | 41.2 | 12% |
|
| Institutional Ownership | 85.9% | 83.3% | 54% |
|
| Float (Mil) | 3.6 | 35.5 | 9% |
|
| Beta | 1.64 | 0.85 | 85% |
|
| Avg Daily Volume (000s) | 35 | 259 | 26% |
|
| Price Change (52-week) |
(39.1%) | 62.9% | 25% |
|
| Growth | RMTI | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 2.2% | 11.8% | 24% |
|
| Net Income (5yr) | 29.7% | (4.8%) | 85% |
|
| EPS (5yr) | 49.2% | 10.6% | 93 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (15.2%) | (15.6%) | 50% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | RMTI | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $69 | $155 | 23% |
|
| Net Income (TTM) (Mil) | ($5) | ($9) | 33% |
|
| EPS (TTM) | ($1.356) | ($0.400) | 18% |
|
| Operating Cash Flow (TTM) (Mil) | $3 | ($2) | 35% |
|
| Net Cash Flow (TTM) (Mil) | ($2) | $1 | 38% |
|
| Long-Term Debt (Q1) (Mil) | $10 | $28 | 29% |
|
| Enterprise Value (Q1) (Mil) | $21 | $437 | 11% |
|
| Valuation | RMTI | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.79 | 2.52 | 18% |
|
| P/E | na | 26.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.5 | na |
|
| Ratios | RMTI | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 17.7% | 59.0% | 18% |
|
| Net Margin | (7.3%) | (6.9%) | 23% |
|
| ROA | (9.3%) | (12.2%) | 26% |
|
| ROE | (15.5%) | (10.5%) | 25% |
|
| Liabilities to Assets | 37.9% | 47.2% | 29% |
|
| F-Score | 5 | 4 | 50% |
|
Rockwell Medical, Inc. did not pass any screens on 10/23/2026.
